Versuchen GOLD - Frei
This Buffett devotee is plowing billions into crypto
Mint Mumbai
|September 16, 2025
Capital Group is a 94-year-old mutualfund juggernaut known for its disciplined investing style. Mark Casey, a portfolio manager with 25 years of experience at the firm, quotes pioneering value-investor Benjamin Graham and says his "approach is very informed by Warren Buffett.
That is why it is so surprising that Capital Group has placed a huge bet on bitcoin—one of the largest by a mainstream investment firm—and that Casey has emerged as one of most outspoken backers of the digital currency in the so-called TradFi world.
"I just love bitcoin, I just think it is so interesting," Casey, 54, said on a podcast interview hosted by venturecapital firm Andreessen Horowitz last year, calling it "one of the coolest things that has ever been created by people."
In the past four years, Casey and his firm have turned less than $1 billion into more than $6 billion with investments in Strategy and other so-called bitcoin treasury companies whose sole focuses are loading up on the cryptocurrency.
Behind the bullishness: A view that bitcoin is replacing gold as a modern-day means of storing value—and will prove more useful than gold. Over time, bitcoin's price will rise, Casey and some others at Capital Group argue, catching up to or even exceeding the value of gold, which currently accounts for roughly 2% of global wealth according to some estimates. By contrast, Casey is dubious other cryptocurrencies will ever prove valuable, even as rivals pile into ether.
Diese Geschichte stammt aus der September 16, 2025-Ausgabe von Mint Mumbai.
Abonnieren Sie Magzter GOLD, um auf Tausende kuratierter Premium-Geschichten und über 9.000 Zeitschriften und Zeitungen zuzugreifen.
Sie sind bereits Abonnent? Anmelden
WEITERE GESCHICHTEN VON Mint Mumbai
Mint Mumbai
Gen Alpha will make new rules for their workplace
Gen Alpha will expect hybrid workplaces, Al tools and 4-day weeks— offices unrecognizable to their parents’
3 mins
December 01, 2025
Mint Mumbai
EC extends electoral roll revision by a week to II Dec; final list on 14 Feb
The Election Commission on Sunday extended by one week the entire schedule of the ongoing special intensive revision (SIR) of electoral rolls in nine states and three Union territories amid allegations by opposition parties that the “tight timelines” were creating problems for people and ground-level poll officials.
2 mins
December 01, 2025
Mint Mumbai
THE PROBLEM IS NOT JUST ABOUT DYNASTIC POLITICS
These days Tejashvi Yadav is the target of intense trolling. Before him the Huda family in Haryana and Thackerays in Maharashtra got the same treatment. So, is the battle of victory and defeat in electoral politics a tussle between dynasts vs the rest? Absolutely not.
3 mins
December 01, 2025
Mint Mumbai
Green hydrogen: Fast fashion could help bump up demand
A boom in its use for clean synthetic inputs might make a difference
3 mins
December 01, 2025
Mint Mumbai
Let's be a bit more selective in using the word 'reforms'
Everybody should take a beat and think before uttering the word ‘reforms’ the next time. Glib usage, frequently in the wrong context, threatens to rob the word of its import.
3 mins
December 01, 2025
Mint Mumbai
As mid-cap alpha shrinks, should you consider passive strategies?
Advisers urge a balanced mix—add passives slowly and back strong, active managers, as mid-caps are still pricey
4 mins
December 01, 2025
Mint Mumbai
With $2.2 bn fund, ChrysCap has appetite for riskier bets
MD Saurabh Chatterjee details shift in global LP base, renewed focus on manufacturing
3 mins
December 01, 2025
Mint Mumbai
GDP growth of 8% plus: How to sustain this pace
Last quarter's economic expansion has cheered India but the challenge is to sustain a brisk rate for years to come. For private investment to chip in, revive infrastructure partnerships
2 mins
December 01, 2025
Mint Mumbai
INSIDE INDIA'S ATTEMPT TO TAME DEEPFAKES
Detection tools today are not universal or consistent across languages
5 mins
December 01, 2025
Mint Mumbai
APIs to innovation: Bulk drug makers ramp up CDMO bets
Once focused on low-margin active pharmaceutical ingredients (APIs), India’s bulk drug manufacturers are raising their ambitions, with several now investing heavily in research and development to win contract development and manufacturing work from global drugmakers.
2 mins
December 01, 2025
Listen
Translate
Change font size

